Yanfeng Dai

1.0k total citations
10 papers, 806 citations indexed

About

Yanfeng Dai is a scholar working on Molecular Biology, Microbiology and Immunology. According to data from OpenAlex, Yanfeng Dai has authored 10 papers receiving a total of 806 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Molecular Biology, 4 papers in Microbiology and 4 papers in Immunology. Recurrent topics in Yanfeng Dai's work include Immunotherapy and Immune Responses (4 papers), Antimicrobial Peptides and Activities (4 papers) and Nanoplatforms for cancer theranostics (3 papers). Yanfeng Dai is often cited by papers focused on Immunotherapy and Immune Responses (4 papers), Antimicrobial Peptides and Activities (4 papers) and Nanoplatforms for cancer theranostics (3 papers). Yanfeng Dai collaborates with scholars based in China, Canada and South Korea. Yanfeng Dai's co-authors include Zhihong Zhang, Qingming Luo, Lisen Lu, Xiang Yu, Sha Qiao, Yuan Qian, Guoqiang Xu, Bolei Dai, Yifan Zhao and Shuhong Qi and has published in prestigious journals such as Nature Communications, ACS Nano and Biomaterials.

In The Last Decade

Yanfeng Dai

10 papers receiving 800 citations

Peers

Yanfeng Dai

IMMUN

BE

MB

ONCOL

BIOMA

Shuhong Qi China

Meilyn Sylvestre United States

Zhongfeng Ye United States

Na Kyeong Lee South Korea

Gabrielle Hochu United States

Kazunori Koiwai Japan

Young Seob Kim South Korea

Liping Zuo China

Neelesh Soman United States

Junqiang Ding China

Shuhong Qi China

Yanfeng Dai

240 ×0.5

IMMUN

215 ×0.6

BE

190 ×0.6

MB

88 ×0.5

ONCOL

84 ×0.6

BIOMA

Citations per year, relative to Yanfeng Dai Yanfeng Dai (= 1×) peers Shuhong Qi

Countries citing papers authored by Yanfeng Dai

Since Specialization

Citations

This map shows the geographic impact of Yanfeng Dai's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yanfeng Dai with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yanfeng Dai more than expected).

Fields of papers citing papers by Yanfeng Dai

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yanfeng Dai. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yanfeng Dai. The network helps show where Yanfeng Dai may publish in the future.

Co-authorship network of co-authors of Yanfeng Dai

This figure shows the co-authorship network connecting the top 25 collaborators of Yanfeng Dai. A scholar is included among the top collaborators of Yanfeng Dai based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yanfeng Dai. Yanfeng Dai is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

10 of 10 papers shown

1.

Dai, Yanfeng, Xiang Yu, Yifan Zhao, et al.. (2025). Targeted Modulation of the Meningeal Lymphatic Reverse Pathway for Immunotherapy of Breast Cancer Brain Metastases. ACS Nano. 19(4). 4830–4844. 6 indexed citations

2.

Wang, Junjie, Jianshuang Wei, Yanfeng Dai, et al.. (2023). In situ phagocyte-mediated deep tumor penetration assisted by ApoA-1 mimetic peptide-modified silicasome. Nano Today. 50. 101864–101864. 8 indexed citations

3.

Yu, Xiang, Siyu Jia, Yu Shi, et al.. (2023). Recent advances in melittin-based nanoparticles for antitumor treatment: from mechanisms to targeted delivery strategies. Journal of Nanobiotechnology. 21(1). 454–454. 32 indexed citations

4.

Dai, Yanfeng, et al.. (2023). Effective treatment of metastatic sentinel lymph nodes by dual-targeting melittin nanoparticles. Journal of Nanobiotechnology. 21(1). 245–245. 12 indexed citations

5.

Yu, Xiang, Yanfeng Dai, Yifan Zhao, et al.. (2020). Melittin-lipid nanoparticles target to lymph nodes and elicit a systemic anti-tumor immune response. Nature Communications. 11(1). 1110–1110. 196 indexed citations

6.

Dai, Yanfeng, Xiang Yu, Jianshuang Wei, et al.. (2020). Metastatic status of sentinel lymph nodes in breast cancer determined with photoacoustic microscopy via dual-targeting nanoparticles. Light Science & Applications. 9(1). 164–164. 47 indexed citations

7.

Qian, Yuan, Sha Qiao, Yanfeng Dai, et al.. (2017). Molecular-Targeted Immunotherapeutic Strategy for Melanoma via Dual-Targeting Nanoparticles Delivering Small Interfering RNA to Tumor-Associated Macrophages. ACS Nano. 11(9). 9536–9549. 300 indexed citations

8.

Jin, Honglin, Yuan Qian, Yanfeng Dai, et al.. (2016). Magnetic Enrichment of Dendritic Cell Vaccine in Lymph Node with Fluorescent-Magnetic Nanoparticles Enhanced Cancer Immunotherapy. Theranostics. 6(11). 2000–2014. 77 indexed citations

9.

Qian, Yuan, Honglin Jin, Sha Qiao, et al.. (2016). Targeting dendritic cells in lymph node with an antigen peptide-based nanovaccine for cancer immunotherapy. Biomaterials. 98. 171–183. 127 indexed citations

10.

Dai, Yanfeng. (2004). 6 Using new teaching strategies to improve teaching and learning in Organic Chemistry. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact